在Kleefstra综合征中的电临床特征
Thea Giacomini1,2, Ramona Cordani1,3, Irene Bagnasco4
1Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health (DINOGMI), University of Genova, Genova, Italy.
Neuropediatrics
|October 6, 2023
概括
克莱夫斯特拉综合征 (KS) 患者经常出现,通常呈现为焦点发作. 在KS中早期发作的与更频繁的发作有关,尽管随着时间的推移,频率会下降.
科学领域:
- 遗传学和神经学 遗传学和神经学
- 罕见的遗传疾病 罕见的遗传疾病
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 克莱夫斯特拉综合征 (KS),也称为9q34.3微删除综合征,是一种罕见的遗传疾病,具有智力障碍,低血压和异形特征.
- 虽然会影响20-30%的KS患者,但其特征和原因的详细描述是有限的.
- KS可能是EHMT1基因中的9q34.3微切除或致病变体的结果.
研究的目的:
- 为了研究诊断为Kleefstra综合征的患者队列中的特定特征.
- 探索基因原因 (微删除与EHMT1变体) 与KS特征之间的关系.
- 为了比较患者队列中的发现与现有的关于的文献数据.
主要方法:
- 一项多中心研究,涉及8名患有克莱夫斯特拉综合征和的患者.
- 包括标准包括9q34.3删除,EHMT1变异或涉及EHMT1.1的复杂转位的患者.
- 分析了临床数据,包括发作类型,发病率,频率和对治疗的反应,并与文献进行了比较.
主要成果:
- 该研究包括了缺失,EHMT1变异和转位的患者,所有这些患者都有发育迟缓,语言障碍,小头症和低血压.
- 的表现是多样化的,主要是焦点发作;早期发作的 (在36个月之前) 与更高的发作频率相关.
- 所有患者的发作频率和抗药物需求随着时间的推移而减少;发育迟缓的严重程度与的特征无关.
结论:
- 是克莱夫斯特拉综合征的一个常见且显著的特征.
- 在KS中的特定病原遗传机制和详细的临床特征需要进一步阐明.
- 观察到的发作模式表明了治疗管理的潜力,并随着时间的推移改善了结果.
更多相关视频
09:32Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
12.4K
09:00Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex
Published on: April 15, 2015
12.3K
相关概念视频
01:13Seizures: Classification
384
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
384
01:24Arteries of the Lower Limbs
198
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
198
01:20Antiepileptic Drugs: Potassium Channel Activators
196
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
196
01:30Electroconvulsive Therapy
50
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
50
01:17Antiepileptic Drugs: Calcium Channel Blockers
426
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
426